-
Purpose(Empty Backbone) Natively produces mScarlet, in the presence of Cre will be recombined to produce mNeon.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 125139 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCax
- Backbone size (bp) 6734
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameNone
-
MutationRemoved Not1 site in mScarlet
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Intent is to introduce low doses of pCAG Cre to recombine a subset of cells, such that mScarlet can act as an internal control to mNeon for use in in utero electroporation or other related techniques. Genetic overexpression can be easily attached following the mNeon through use of a mcs after the P2A.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Double UP mScarlet to mNeon was a gift from Erik Dent (Addgene plasmid # 125139 ; http://n2t.net/addgene:125139 ; RRID:Addgene_125139) -
For your References section:
Double UP: A Dual Color, Internally Controlled Platform for in utero Knockdown or Overexpression. Taylor RJ, Carrington J, Gerlach LR, Taylor KL, Richters KE, Dent EW. Front Mol Neurosci. 2020 May 20;13:82. doi: 10.3389/fnmol.2020.00082. eCollection 2020. 10.3389/fnmol.2020.00082 PubMed 32508591